Pages that link to "Q37836255"
Jump to navigation
Jump to search
The following pages link to Clinical Importance of OATP1B1 and OATP1B3 in DrugDrug Interactions (Q37836255):
Displaying 28 items.
- How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion (Q24273350) (← links)
- New insights in bilirubin metabolism and their clinical implications (Q26863145) (← links)
- Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors (Q28239708) (← links)
- Presurgical pulmonary evaluation in renal transplant patients. (Q34907951) (← links)
- Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Atorvastatin (Q35270890) (← links)
- Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy. (Q36616448) (← links)
- Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors. (Q37113947) (← links)
- A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine (Q37470663) (← links)
- Current understanding of hepatic and intestinal OATP-mediated drug-drug interactions. (Q37960129) (← links)
- Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding. (Q38051400) (← links)
- Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption (Q38056878) (← links)
- Drug interactions with statins (Q38155016) (← links)
- Enzyme- and transporter-mediated beverage-drug interactions: An update on fruit juices and green tea. (Q38533636) (← links)
- A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction. (Q38655266) (← links)
- Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models (Q38827713) (← links)
- Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites (Q38888365) (← links)
- Disposition pathway-dependent approach for predicting organic anion-transporting polypeptide-mediated drug-drug interactions (Q39451287) (← links)
- Effect of Steady-State Faldaprevir on Pharmacokinetics of Atorvastatin or Rosuvastatin in Healthy Volunteers: A Prospective Open-Label, Fixed-Sequence Crossover Study (Q40198351) (← links)
- Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus Monkeys (Q46201971) (← links)
- Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers (Q48600898) (← links)
- Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database (Q56888883) (← links)
- Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation (Q57053200) (← links)
- Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies (Q59127470) (← links)
- Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter (Q64331279) (← links)
- Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology. (Q64932041) (← links)
- Insertion of LINE-1 Retrotransposon Inducing Exon Inversion Causes a Rotor Syndrome Phenotype (Q89820812) (← links)
- Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease (Q96304545) (← links)
- Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis (Q98465610) (← links)